January 7, 2019
4D pharma to test its diverse cancer settings Live Biotherapeutic oncology pipeline with University of Texas MD Anderson Cancer Center
4D pharma and The University of Texas MD Anderson Cancer Center will together work on testing 4D’s Live Biotherapeutic oncology pipeline across a range of cancer settings, the company said on Monday in a press release